DANAHER CORPORATION's ticker is DHR and the CUSIP is 235851102. A total of 1,798 filers reported holding DANAHER CORPORATION in Q2 2021. The put-call ratio across all filers is 1.06 and the average weighting 0.6%.
About DANAHER CORPORATION
Danaher Corporation is a global science and technology company that designs, manufactures, and markets innovative products and services to professional, medical, industrial, and commercial customers. The company operates through four segments: Life Sciences, Diagnostics, Dental, and Environmental & Applied Solutions.
Danaher's Life Sciences segment provides a range of research tools to scientists around the world, including mass spectrometry, chromatography, and automation systems. The Diagnostics segment offers a broad range of diagnostic products, including clinical chemistry, immunoassay, microbiology, and molecular diagnostic systems. The Dental segment provides a range of dental equipment and consumables, including imaging systems, dental instruments, and consumables. The Environmental & Applied Solutions segment offers a range of products and services to help customers protect the environment and improve productivity.
Danaher has a strong track record of growth and innovation, driven by its focus on continuous improvement and customer satisfaction. The company has a culture of operational excellence, which has enabled it to consistently deliver high-quality products and services to its customers. Danaher's management team is highly experienced and has a proven track record of creating value for shareholders.
In conclusion, Danaher Corporation is a well-established and innovative company that is well-positioned to continue delivering strong growth and value to its shareholders. With its focus on operational excellence and customer satisfaction, Danaher is a company that investors should keep an eye on.
It's important to note that this information is for educational purposes only and has not been fact-checked. As with any investment, it's important to do your own research and consult with a financial advisor before making any investment decisions.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $491,996,690 | -1.7% | 1,983,058 | -4.9% | 0.84% | +3.7% |
| Q2 2023 | $500,321,520 | +0.8% | 2,084,673 | +5.8% | 0.80% | -1.5% |
| Q1 2023 | $496,464,863 | -8.8% | 1,969,786 | -4.0% | 0.82% | -15.2% |
| Q4 2022 | $544,595,922 | -14.2% | 2,051,827 | -16.5% | 0.96% | -13.7% |
| Q3 2022 | $634,834,000 | +23.1% | 2,457,836 | +20.8% | 1.12% | +28.0% |
| Q2 2022 | $515,883,000 | -30.9% | 2,034,881 | -20.1% | 0.87% | -11.6% |
| Q1 2022 | $746,913,000 | -25.3% | 2,546,324 | -16.2% | 0.99% | -16.7% |
| Q4 2021 | $999,474,000 | -5.8% | 3,037,824 | -12.8% | 1.18% | -8.6% |
| Q3 2021 | $1,060,487,000 | +26.1% | 3,483,403 | +11.1% | 1.30% | +29.1% |
| Q2 2021 | $841,233,000 | +14.7% | 3,134,719 | -3.8% | 1.00% | +8.1% |
| Q1 2021 | $733,590,000 | +2.8% | 3,259,241 | +1.4% | 0.93% | +6.7% |
| Q4 2020 | $713,681,000 | +1.7% | 3,212,754 | -1.4% | 0.87% | -12.2% |
| Q3 2020 | $701,700,000 | +66.9% | 3,258,718 | +37.1% | 0.99% | +47.3% |
| Q2 2020 | $420,393,000 | +74.1% | 2,377,386 | +36.3% | 0.67% | +30.2% |
| Q1 2020 | $241,497,000 | +782.4% | 1,744,796 | +878.5% | 0.52% | +977.1% |
| Q4 2019 | $27,369,000 | -33.6% | 178,321 | -37.6% | 0.05% | -38.5% |
| Q3 2019 | $41,244,000 | -2.0% | 285,564 | -3.0% | 0.08% | 0.0% |
| Q2 2019 | $42,070,000 | +103.6% | 294,361 | +88.1% | 0.08% | +90.2% |
| Q1 2019 | $20,659,000 | -50.2% | 156,486 | -61.1% | 0.04% | -56.4% |
| Q4 2018 | $41,519,000 | +207.9% | 402,631 | +224.5% | 0.09% | +261.5% |
| Q3 2018 | $13,483,000 | +106.8% | 124,080 | +87.8% | 0.03% | +100.0% |
| Q2 2018 | $6,520,000 | – | 66,067 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| ARTHUR M. COHEN & ASSOCIATES, LLC | 217,436 | $53,823,432 | 13.80% |
| Defender Capital, LLC. | 152,962 | $37,949,802 | 13.74% |
| Bancreek Capital Management, LP | 60,890 | $15,106,809 | 13.58% |
| BOONE CAPITAL MANAGEMENT LLC | 129,163 | $32,045,340 | 10.11% |
| Eagle Health Investments LP | 175,085 | $43,438,589 | 9.57% |
| Third Point | 2,450,000 | $607,845,000 | 9.22% |
| Clio Asset Management LLC | 41,695 | $10,344,530 | 9.04% |
| Consulta Ltd | 500,000 | $124,050,000 | 8.91% |
| Riverstone Advisors, LLC | 47,960 | $11,799,701 | 8.16% |
| CADEN CAPITAL PARTNERS, LP | 123,755 | $27,215,377 | 7.66% |